Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SHR8554 for postoperative analgesia after laparoscopic lower abdominal surgery
CTR20192082Phase 2Active
- Sponsor
- Hengrui Therapeutics
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegileridine in postoperative pain, sponsored by Hengrui Therapeutics. Started Nov 2019; status: active.
02
Drugs
tegileridine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on CTR20192082.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20192082.